ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism
Clinical Genetics · 2024
DOI: 10.1111/cge.14506 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Genetics, 2024. Verfasst von Emily Woods und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. Hauptthemen laut MEDLINE: Developmental Disabilities, Intellectual Disability, Abnormalities, Multiple, Facies. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
ASXL3‐related disorder, sometimes referred to as Bainbridge‐Ropers syndrome, was first identified as a distinct neurodevelopmental disorder by Bainbridge et al. in 2013. Since then, there have been a number of case series and single case reports published worldwide. A comprehensive review of the literature was carried out. Abstracts were screened, relevant literature was analysed, and descriptions of common phenotypic features were quantified. ASXL3 variants were collated and categorised. Common phenotypic features comprised global developmental delay or intellectual disability (97%), feeding problems (76%), hypotonia (88%) and characteristic facial features (93%). The majority of genetic variants were de novo truncating variants in exon 11 or 12 of the ASXL3 gene. Several gaps in our knowledge of this disorder were identified, namely, underlying pathophysiology and disease mechanism, disease contribution of missense variants, relevance of variant location, prevalence and penetrance data. Clinical information is currently limited by patient numbers and lack of longitudinal data, which this review aims to address.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
- Sheffield Diagnostic Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
- The Bateson Centre, University of Sheffield, Sheffield, UK.
ORCID-Profile: Emily Woods, Iwan R Evans, Meena Balasubramanian
Förderung
- Medical Research Council
Zitieren
APA
Woods, E., Holmes, N., Albaba, S., Evans, I. R., & Balasubramanian, M. (2024). ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism. Clinical Genetics. https://doi.org/10.1111/cge.14506
Vancouver
Woods E, Holmes N, Albaba S, Evans IR, Balasubramanian M. ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism. Clinical Genetics. 2024. doi:10.1111/cge.14506
BibTeX
@article{Woods2024,
author = {Woods, Emily and Holmes, Nicola and Albaba, Shadi and Evans, Iwan R and Balasubramanian, Meena},
title = {ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism},
journal = {Clinical Genetics},
year = {2024},
doi = {10.1111/cge.14506}
}
EUVIMED